{"id":618012,"date":"2026-10-02T02:24:18","date_gmt":"2026-10-02T02:24:18","guid":{"rendered":"https:\/\/www.newsbeep.com\/nz\/618012\/"},"modified":"2026-10-02T02:24:18","modified_gmt":"2026-10-02T02:24:18","slug":"obio-marks-1bn-funding-milestone-for-canadian-health-tech-ventures","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/nz\/618012\/","title":{"rendered":"OBIO marks $1bn funding milestone for Canadian health tech ventures"},"content":{"rendered":"

\"\"\/<\/p>\n

OBIO delivers infrastructure, advocacy, and strategic programming across the medtech, digital health, therapeutics, and diagnostic fields. Credit: Gorodenkoff\/Shutterstock.com.<\/p>\n

Life sciences and technology companies supported by the Ontario Bioscience Innovation Organization\u2019s (OBIO) Capital Access Advisory Program (CAAP) have collectively raised more than C$1bn ($704.7m) in capital.<\/p>\n

The initiative is supported by the Government of Canada through the Federal Economic Development Agency for Southern Ontario.<\/p>\n

\"\"\/ Discover B2B Marketing That Performs <\/p>\n

\n\t\t\t\t\t\tCombine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.\n\t\t\t\t\t<\/p>\n


\n\t\t\t\t\t\t\tFind out more <\/a><\/p>\n

It is designed to help post-seed health science enterprises secure venture investment, form corporate partnerships, and commercialise technologies.<\/p>\n

Alongside reaching the financial milestone, OBIO confirmed the six enterprises selected for its 2026 intake.<\/p>\n

The new cohort includes Toronto-based AI. Vali, which specialises in AI-guided diagnostic imaging analysis, and Hamilton-based Block Biosciences that is developing therapies to prevent cancer spreading to the brain.<\/p>\n

Ottawa-based Hylid Diagnostics also joins the group with its optical sensor technology for at-home blood testing in kidney disease and heart failure patients.<\/p>\n

The remaining participants are all based in Toronto: Orb Therapeutics, a ribonucleic acid (RNA) therapy developer; Synakis, a pre-clinical start-up targeting ocular diseases such as glaucoma; and Thornhill Medical, creator of the RespirAct brain stress test system.<\/p>\n

All six companies will receive strategic commercial planning and introductions to potential investors and industry partners.<\/p>\n

They will also present at the OBIO Investment Summit in Toronto from 2 to 4 February 2027, an event where presenting enterprises have raised more than C$3.1bn since 2018.<\/p>\n

OBIO president and CEO Dr Maura Campbell said: \u201cReaching this C$1bn milestone is a testament to the world-class innovation emerging from Canada\u2019s health science sector and to the effectiveness of OBIO\u2019s targeted approach.<\/p>\n

\u201cThrough CAAP, we not only equip founders with intensive coaching, but also provide actionable commercial strategies and direct access to global capital networks via our annual OBIO Investment Summit.<\/p>\n

\u201cEvery dollar raised by our programme alumni contributes to the creation of new jobs, concrete clinical advancements, and the scaling of Canadian health technologies on the global stage.\u201d<\/p>\n

Till date, 127 health science businesses have graduated from the advisory scheme, with 65% securing capital or strategic partnerships within 18 months of completing the programme.<\/p>\n

Established in 2009, OBIO is a not-for-profit, membership-led entity providing strategy, programming, and commercialisation support for diagnostics, medical technology, therapeutics, and digital health businesses across Canada.<\/p>\n

\"Email<\/p>\n

\n Sign up for our daily news round-up!
\n Give your business an edge with our leading industry insights.\n <\/p>\n","protected":false},"excerpt":{"rendered":"OBIO delivers infrastructure, advocacy, and strategic programming across the medtech, digital health, therapeutics, and diagnostic fields. Credit: Gorodenkoff\/Shutterstock.com.…\n","protected":false},"author":2,"featured_media":618013,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[134,527,111,139,69],"class_list":["post-618012","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-health","tag-healthcare","tag-new-zealand","tag-newzealand","tag-nz"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/618012","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=618012"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/618012\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/618013"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=618012"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=618012"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=618012"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}